A once-overlooked traditional remedy is receiving fresh attention from scientists, as compounds found in Artemisia afra—commonly known as African wormwood—demonstrate promising therapeutic potential against two major respiratory illnesses: asthma and tuberculosis. Though long used in African herbal medicine, modern research is now validating some of its most storied uses and pointing toward future drug development opportunities.
Researchers recently published findings in the journal Evidence-Based Complementary and Alternative Medicine indicating that a compound derived from African wormwood may help alleviate asthma symptoms. The compound was shown to reduce airway inflammation, enhance respiratory function, and potentially lower the frequency and severity of asthma attacks—effectively complementing conventional asthma medications. Although the compound’s current potency requires enhancement for clinical application, its observed anti-inflammatory and antioxidative effects mark a significant step in alternative respiratory care.
Asthma remains a chronic condition of global concern. Characterized by inflamed and constricted airways, the disease manifests in recurring bouts of breathlessness, wheezing, coughing, and chest tightness. While treatment typically involves inhalers and steroids, poor adherence to medication regimens and side effects often lead patients to explore complementary therapies. Herbal remedies are frequently used, but most lack rigorous scientific validation.
This is changing. A comprehensive review of botanicals with anti-asthmatic properties has identified 58 plants and 32 herbal compounds with potential activity against asthma. Among them are familiar names like black seed (Nigella sativa), turmeric (Curcuma longa), mango leaves (Mangifera indica), mint (Mentha longifolia), and moringa (Moringa oleifera), alongside African wormwood. Many of these plants operate by curbing inflammation and oxidative stress—two core mechanisms in asthma pathophysiology.
Traditionally, African wormwood is used in multiple forms: as decoctions, infusions, poultices, and steam inhalations. In many African households, its syrup form—boiled with honey or sugar—is a trusted remedy for colds, sore throats, bronchitis, and even pneumonia. Steam from the boiled leaves is inhaled for chest relief, and fresh leaves are sometimes inserted in the nostrils to ease nasal congestion. Such practices, once viewed as purely folkloric, are increasingly under scientific investigation.
Beyond asthma, Artemisia afra is also gaining traction in tuberculosis research. A team co-led by researchers at Penn State recently identified a compound in the plant—an O-methylflavone—that effectively kills Mycobacterium tuberculosis (Mtb), the bacteria responsible for TB. Remarkably, the compound was effective against both active and dormant forms of the bacteria—a rare and valuable trait in TB therapeutics.
Tuberculosis remains one of the deadliest infectious diseases worldwide, with about 10 million new cases annually and 1.5 million deaths. Although treatments exist, they are lengthy, often lasting up to six months for drug-sensitive TB and up to two years for resistant strains. Such prolonged therapies come with challenges including cost, adherence, and toxicity.
In the study, researchers fractionated raw extracts of African wormwood and screened them for antibacterial activity against Mtb. One compound stood out for its ability to eliminate bacteria in both oxygen-rich and low-oxygen (hypoxic) environments—the latter being a state the bacteria adopt to survive stress. Tests in human cell models further showed that the compound had minimal toxicity, a crucial factor for future drug development.
“While the potency of this compound is too low to use directly as an anti-Mtb treatment, it may still serve as the foundation for designing more potent drugs,” said Dr. Joshua Kellogg, assistant professor of veterinary and biomedical sciences at Penn State and co-corresponding author of the study. “Furthermore, there appear to be other, similar chemicals in African wormwood that may also have the same type of properties.”
These findings, recently published in the Journal of Ethnopharmacology, underline the importance of revisiting traditional medicinal plants through the lens of modern science. As drug resistance and therapeutic limitations persist, botanicals like African wormwood could offer new directions for treatment—grounded in both ancestral knowledge and evidence-based research.
Though more work is needed to isolate, refine, and test these compounds in clinical settings, the renewed interest in Artemisia afra suggests that the ancient plant may have a future role in modern medicine—not just as a cultural relic, but as a viable source of biomedical innovation.